Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-017416

Controller acquired 3,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tourangeau Greg Controller 2022-05-06 Grant or award +3,250 16,202 D
Derivatives
Tourangeau Greg Controller 2022-05-06 Grant or award · Stock Option (right to buy) +6,500 6,500 D
Loading xslF345X03/doc4.xml…